Analyst Ratings for IMS Health Holdings Inc (IMS)

Updated: 2016-10-01

A number of analysts gave price targets for IMS. The maximum price target given was 34, implying potential capital gains of 8.49 percent. The minimum price target given was 25, which equates to a potential downside of -20.23 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is 2.78 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.91 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts made negative revisions. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 0 analysts that revised their FY estimates downwards.

The growth rate of IMS's earnings is estimated by analysts to be 277.44 percent. Another measure frequently examined by investors is the PEG ratio. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. PEG ratios below 1 are often considered desirable, even though it may be more relevant to compare the ratio to that of a firm's competitors. IMS has a PEG ratio of 0.27.

IMS has a 52-week high of 31.59 and a 52-week low of 22.36. The current market price is above the trailing year's low by 40.16 percent, and 0.79 percent lower than its 52-week high. IMS has a P/E ratio of 75.45. Investors typically compare the P/E ratio to a company's peers in the industry. The IMS value stock report compares IMS to some of its peers using value stock charts. The market cap of IMS is $10.59 billion. IMS will post this quarters earnings in -750 days, on 2016-10-27.